Literature DB >> 4063892

Long-term follow-up of concomitant band ligation and sclerotherapy for internal hemorrhoids.

J Choi, J B Freeman, J Touchette.   

Abstract

From 1978 to 1983, 111 patients with symptomatic internal hemorrhoids were treated as outpatients by a modification of the Barron ligation technique. Each ligated hemorrhoid was injected with a sclerosant. Follow-up, available for 94 of the patients, ranged from 2 to 60 months (mean 18 months). Presenting symptoms were bleeding in 75 (80%) of the 94 patients, pain in 46 (49%), pruritus in 22 (23%) and prolapse in 24 (26%). Results were excellent in 51 (54%) patients, good in 20 (21%) and fair in 9 (10%). Fourteen (15%) patients had unsatisfactory results; only 4 of these required hemorrhoidectomy. The other 10 had residual symptoms but did not require further treatment. Nine patients had minor complications, which included pain lasting 24 to 72 hours in seven, bleeding in one and syncope in one. The addition of sclerotherapy to traditional band ligation for the management of internal hemorrhoids has the advantages of exciting a greater inflammatory reaction between the mucosa and submucosa and preventing premature slipping of the band. The authors conclude that this method of therapy is effective for symptomatic hemorrhoids and that surgical hemorrhoidectomy is seldom indicated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063892

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  4 in total

1.  Conservative management of hemorrhoids: a comparison of venotonic flavonoid micronized purified flavonoid fraction (MPFF) and sclerotherapy.

Authors:  Bulent C Yuksel; Halil Armagan; Huseyin Berkem; Yiğit Yildiz; Hakan Ozel; Suleyman Hengirmen
Journal:  Surg Today       Date:  2008-02-01       Impact factor: 2.549

2.  Sclerobanding Is a Novel Technique for the Treatment of Second- and Third-Degree Hemorrhoidal Disease. Reply to Jongen et al. Comment on "Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218".

Authors:  Francesco Pata; Luigi Maria Bracchitta; Giancarlo D'Ambrosio; Salvatore Bracchitta
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

3.  Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218.

Authors:  Johannes Jongen; Jessica Schneider; Volker Kahlke; Tilman Laubert
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

4.  Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.

Authors:  Francesco Pata; Luigi Maria Bracchitta; Giancarlo D'Ambrosio; Salvatore Bracchitta
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.